Parkinson's disease and the gut: 'The wheel is come full circle'

Journal of Parkinson's Disease

Volumn 4, Issue 4, 2014, Pages 577-578

  Pfeiffer, Ronald F ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DOPAMINERGIC NERVE CELL; GASTRIC DYSMOTILITY; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE INNERVATION; LEWY BODY; NERVE CELL DEGENERATION; NEUROGENIC BOWEL; NEUROPATHOLOGY; NOTE; PARKINSON DISEASE; STOMACH EMPTYING;

EID: 84914704202     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-149007     Document Type: Note

References (18)

1. Parkinson J (1817) An essay on the shaking palsy. London: Whittingham and Rowland.
2. Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol, 2, 107-116.
3. Pfeiffer RF (2011) Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat Disord, 17, 10-15.
4. Kupsky WK, Grimes MM, Sweeting J, Bertsch R & Cote LJ (1987) Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology, 37, 1253-1255.
5. Wakabayashi K, Takahashi H, Ohama E & Ikuta F (1990) Parkinson's disease: An immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol, 79, 581-583.
6. Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R & Quigley EM (1995) Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet, 346, 861-864.
7. Braak H, Rüb U, Gai WP & Del Tredici K (2003) Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm, 110, 517-536.
8. Braak H, de Vos RA, Bohl J & Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's diseaserelated brain pathology. Neurosci Lett, 396, 67-72.
9. Olanow CW & Prusiner SB (2009) Is Parkinson's disease a prion disorder Proc Natl Acad Sci USA, 106, 12571-12572.
10. Olanow CW & Brundin P (2013) Parkinson's disease and alpha synuclein: Is Parkinson's disease a prion-like disorder Mov Disord, 28, 31-40.
11. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS&RossGW (2001) Frequency of bowel movements and the future risk of Parkinson's disease. Neurology, 57, 456-462.
12. Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE & RoccaWA (2009) Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology, 73, 1752-1758.
13. Corbillé A-G, Coron E, Neunlist M, Derkinderen P & Lebouvier T (2014) Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD. J Parkinsons Dis, 4, 571-576.
14. Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG & Greene JG (2012) Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol, 124, 665-680.
15. Zheng LF, Song J, Fan RF, Chen CL, Ren QZ, Zhang XL, Feng XY, Zhang Y, Li LS & Zhu JX (2014) The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra. Acta Physiol (Oxf), 211, 434-446.
16. Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, des Varannes SB, Naveilhan P, Nguyen JM, Neunlist M & Derkinderen P (2013) Colonic inflammation in Parkinson's disease. Neurobiol Dis, 50, 42-48.
17. Clairembault T, Kamphuis W, Leclair-Visonneau L, Rolli-Derkinderen M, Coron E, Neunlist M, Hol EM & Derkinderen P (2014) Enteric GFAP expression and phosphorylation in Parkinson's disease. J Neurochem, 130, 805-815.
18. Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RAE & Kordower JH (2014) Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord, 29, 999-1009.